|Day Low/High||53.55 / 54.82|
|52 Wk Low/High||46.55 / 72.36|
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that it has priced a public offering of $450 million aggregate principal amount of 3.
Check out the names that are showing technical characteristics of bullish or bearish reversal patterns over the last week.
Wexford Science & Technology, LLC today announced that it has become an independent company, owned and operated by its existing management team.
Mergers and high-growth stocks are making the market better and better, Cramer says.
Generate more income with less risk: These quality dividend-paying stocks offer an average high yield of 4.9%.
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that it has completed its previously announced acquisition of substantially all of the life science and medical real estate assets of Wexford Science...
Your retirement portfolio could get a salutary boost from biotech stocks along with ETFs in the sector that have generated large returns in 2016, producing double digit-gains.
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") said today that its Board of Directors declared a regular quarterly dividend of $0.
Cramer likes XPO Logistics but wants no part of GNC Holdings.
Earnings season is far from over, Cramer says, and the Fed chief gives a major speech Friday.
The most recent short interest data has been released for the 07/29/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Cramer is waiting for Constellation Brands shares to pull back and wants more growth from Stonemor Partners.
The Internet is a beast. If you don't feed it, it will eat you alive, Cramer says.
Ventas (VTR) stock is gaining on Friday morning after the REIT reported higher-than-anticipated revenue for the 2016 second quarter.
Trade-Ideas LLC identified Ventas (VTR) as a strong on high relative volume candidate
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced strong earnings on a healthy balance sheet for the second quarter of 2016, driven by excellent performance from the Company's high-quality healthcare and...
Ventas (VTR) is scheduled to post its 2016 second quarter results before Friday’s opening bell.
TheStreet highlights 3 stocks pushing the financial sector higher today.
Cramer is taking Verizon and Hewlett Packard Enterprise but not US Bancorp.
There were many earnings reports today, and many could've been worse, Cramer says.
These blue-chip stocks pay safe, generous dividends and form the foundation of a sturdy retirement portfolio.
TheStreet highlights 3 stocks pushing the real estate industry higher today.
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that it will issue its second quarter 2016 earnings release prior to the opening of trading on the New York Stock Exchange on Friday, July 29, 2016.
Ventas (VTR) stock is declining Wednesday morning after the real estate investment trust agreed to purchase a group of life-science and medical properties from an affiliate of Blackstone (BX).
Trade-Ideas LLC identified Ventas (VTR) as a pre-market mover with heavy volume candidate
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced the pricing of an underwritten public offering of 9,000,000 shares of its common stock for total estimated gross proceeds of approximately $649 million.
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that it is offering 9,000,000 shares of its common stock in an underwritten public offering.
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that it has signed a definitive agreement to acquire substantially all of the life science and medical real estate assets of Wexford Science &...
As the fallout from last week's Brexit vote continues to play havoc in the global markets, U.S. Equity REITs could potentially benefit from the turmoil.
Cramer says he's not giving up on Ventas but he wants nothing to do with Tiffany and Signet.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.